Ali Ahmed Ali
Dubai
Summary
I’m an oncologist with over 12 years of oncology clinical practice, then over 10 years of local and regional different roles in medical affairs. My core passion is healthcare innovation, identifying unmet medical needs and driving sustainable, impactful solutions to address them. I am always committed to being adaptable and responsive to a rapidly evolving healthcare landscape to deliver meaningful value to patients
Overview
23
23
years of professional experience
Work History
Middle East and Turkey Clinical Study Unit MDA
Sanofi Genzyme Greater Gulf MCO
09.2024 - Current
- I am also responsible for assessing the feasibility of ongoing and upcoming Phase I, II and III studies across various therapeutic pipelines, Oncology, Immunology and inflammation, rare diseases.
- My role involves overseeing the implementation and operational success of initiated trials, ensuring timely execution and enabling a consistent stream of scientific output including publications, conference presentations, and educational materials.
- A core aspect of my responsibilities is building and sustaining strong relationships and collaboration within the medical and research communities.
- Since I joined, I successfully managed 13 Feasibility, with many studies are currently on startup phase.
Associate Director/Medical Lead (Oncology, Hematology, and Rare Blood Disorders) Greater Gulf
Sanofi Genzyme Greater Gulf MCO
01.2022 - 08.2024
- I served my team in different product pre launches readiness in different therapeutic areas, including Amcenestrant, in breast cancer, Isatuximab for multiple myeloma, Caplacizumab for TTP, Fitusiran for hemophilia, and Rilzabrutinib for ITP
- I have been involved in shaping and executing above-brand strategies in alignment with regional and global teams. This includes the development and execution of medical education programs tailored to key opinion leaders, include insight generation, scientific exchange and clinical best practices sharing.
- Managed many Patient Support Programs, diagnostic initiatives to facilitate screening and early detection and efficient management of TTP and hemophilia patients.
- Supported my team to oversee several global multicenter clinical trials, including pivotal Phase II studies such as IONA and ATLAS NEO, as well RWE projects like REPAIR and ATHENA, plus local scientific publications within the Greater Gulf region.
- Collaborated on development of MOUs and initiatives with key health authorities including MOH, SFDA, DOH, and DHA, along with various hemophilia patient associations in collaboration with regulatory, Access and Public affairs.
Squad Team Lead (Commercial Lead)
Hoffmann-La Roche
01.2020 - 12.2021
- In my role as Squad Team Lead, I provided cross-functional leadership by coordinating closely with key functions including Medical, Commercial, Market Access, and Regulatory to ensure cohesive strategy execution and aligned objectives.
- I played a role in strengthen medical-commercial synergy, enabling effective alignment that supported successful product launches and market readiness.
- A core focus of my leadership was on team proficiency development, identifying capability gaps, facilitating targeted training, and empowering team members to perform at their highest potential with a new implemented Agile methodology.
- I successfully led a cross-functional team to manage the post launch of Emicizumab for Hemophilia and Alecitinib for Lung Cancer.
- Led numerous projects in collaboration with MOH, Saudi FDA, and Hemophilia Patient Association Groups, working alongside the regulatory, Market Access and Communication teams
Middle East Hub Medical Lead
Hoffmann-La Roche
05.2018 - 01.2020
- In this regional Assignment, through bridging and alignment between global and local medical teams across Middle East by harmonizing planning and execution of Roche’s global strategies with local tactics and clinical trial activities to support successful launch of Emicizumab across region.
- My role included strategic KOL management and HCP engagement, driving scientific partnerships and ensuring high-impact medical communication.
- I led external collaborations with key healthcare stakeholders, contributing to scientific leadership and positioning organization as trusted partner in advancing hemophilia care.
- Additionally, I supported reimbursement strategies through a strong medical value proposition in collaboration, integrating Health Economics & Outcomes Research (HEOR) insights to support access, policy engagement, and long-term treatment optimization.
Country Medical Manager (Oncology, Hemophilia and Biosimilar Readiness)
Hoffmann-La Roche
06.2016 - 01.2020
- In this role, I effectively managed pre-Lunch of Emicizumab in Hemophilia, Alecitinib in Lung cancer and Herceptin in Breast cancer.
- Initiated and managed two global multicenter clinical trials (STASEY & RESHAP) in hemophilia in collaboration with Clinical operation team.
- Initiated local diagnostic strategy to support patients with Hemophilia to promote diagnosis and quick management through well-developed patient Support & Assistance Programs
- Led many projects in collaboration with MOH, Saudi FDA and Hemophilia Patient Association Groups in collaboration with Market access ,Public affairs, and communication teams
Regional Medical Advisor Hemophilia and Coagulation Disorders
Novo Nordisk
08.2014 - 05.2016
- In this role, I effectively managed the pre-Lunch of Novoeight and Novothirteen for Hemophilia and Factor XIII deficiency.
- Initiated and managed local publications in Greater Gulf region in collaboration with key scientific leaders in Rare blood disorders.
- Managed local testing program to support patients with Hemophilia with inhibitors.
Assistant Consultant Adult Medical Oncology
Princess Norah Oncology Center
01.2008 - 01.2014
- I served as a medical oncologist, providing care for a diverse range of solid tumors including breast cancer and lymphomas at Princess Norah Oncology Center, NGH Jeddah.
Product Specialist (Oncology)
Baxter oncology
01.2006 - 01.2008
Resident of clinical oncology
Clinical Oncology Department
01.2003 - 01.2006
Education
Clinical Research and Health informatics - Professional Aspects of Epidemiology and Health Research course - International course of Human Protection in Clinical Research from NIH
Drug discovery and development
Harvard Medical School
09.2023
Immuno-oncology and cancer genetics
Harvard Medical School
03.2023
Designing and implementation of AI solutions in healthcare
Harvard Medical School
01.2023
Master's degree - Clinical oncology
01.2008
Bachelor of Medicine and Surgery - undefined
01.2002
Skills
Pharmaceutical Leadership Medical Affairs Strategic planning Breast Cancer Oncology Medical affairs Leadership Team management KOL engagement Scientific communication Clinical trials Health Policy engagement Healthcare Project management Real world evidence generation Products launches and life cycle management Healthcare ecosystems partnerships Medical governance Cross functional collaboration
Timeline
Middle East and Turkey Clinical Study Unit MDA
Sanofi Genzyme Greater Gulf MCO
09.2024 - Current
Associate Director/Medical Lead (Oncology, Hematology, and Rare Blood Disorders) Greater Gulf
Sanofi Genzyme Greater Gulf MCO
01.2022 - 08.2024
Squad Team Lead (Commercial Lead)
Hoffmann-La Roche
01.2020 - 12.2021
Middle East Hub Medical Lead
Hoffmann-La Roche
05.2018 - 01.2020
Country Medical Manager (Oncology, Hemophilia and Biosimilar Readiness)
Hoffmann-La Roche
06.2016 - 01.2020
Regional Medical Advisor Hemophilia and Coagulation Disorders
Novo Nordisk
08.2014 - 05.2016
Assistant Consultant Adult Medical Oncology
Princess Norah Oncology Center
01.2008 - 01.2014
Product Specialist (Oncology)
Baxter oncology
01.2006 - 01.2008
Resident of clinical oncology
Clinical Oncology Department
01.2003 - 01.2006
Drug discovery and development
Harvard Medical School
Immuno-oncology and cancer genetics
Harvard Medical School
Designing and implementation of AI solutions in healthcare
Harvard Medical School
Master's degree - Clinical oncology
Bachelor of Medicine and Surgery - undefined
Clinical Research and Health informatics - Professional Aspects of Epidemiology and Health Research course - International course of Human Protection in Clinical Research from NIH
Similar Profiles
Carlos Peralta PascualCarlos Peralta Pascual
VP, Global Medical Head of Dermatology - Dupixent at Sanofi-GenzymeVP, Global Medical Head of Dermatology - Dupixent at Sanofi-Genzyme
JONATHAN KWASI AHIABAJONATHAN KWASI AHIABA
Manufacturing Associate at Sanofi GenzymeManufacturing Associate at Sanofi Genzyme
Cole MurrayCole Murray
Area Business Manager at Sanofi GenzymeArea Business Manager at Sanofi Genzyme
Macy GillMacy Gill
Dancer at Gatsby DubaiDancer at Gatsby Dubai
SADIQ ABBASSADIQ ABBAS
Banking Advisor at Fintrek Marketing Management LLCBanking Advisor at Fintrek Marketing Management LLC